LeMaitre Vascular Inc

LMAT

Add to Watchlist

97.310USD

-2.190-2.20%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking

30 / 206

Overall Ranking

104 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

LeMaitre Vascular Inc Highlights

StrengthsRisks

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 249.60M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.

Undervalued

The company’s latest PE is 35.38, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 23.53M shares, increasing 3.50% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 47.00 shares of this stock.

Analyst Rating

Based on 10 analysts

Buy

Current Rating

119.778

Target Price

+22.01%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of LeMaitre Vascular Inc is 8.84, ranking 16 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 66.55M, representing a year-over-year increase of 11.16%, while its net profit experienced a year-over-year increase of 42.39%.

Score

Industry at a Glance

Previous score

8.84

Change

0



Financials

8.22

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.41

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.29

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.87

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.40

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of LeMaitre Vascular Inc is 4.49, ranking 189 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 35.38, which is 105.74% below the recent high of 72.80 and 4.03% above the recent low of 33.96.

Score

Industry at a Glance

Previous score

4.49

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 30/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of LeMaitre Vascular Inc is 7.80, ranking 117 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 108.00, with a high of 120.00 and a low of 90.00.

Score

Industry at a Glance

Previous score

7.80

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of LeMaitre Vascular Inc is 6.80, ranking 88 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 110.35 and the support level at 89.86, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.98

Change

-0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of LeMaitre Vascular Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 102.98%, representing a quarter-over-quarter increase of 8.41%. The largest institutional shareholder is PRFDX, holding a total of 268.80K shares, representing 1.18% of shares outstanding, with 0.93% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

2.89M

+0.70%

Conestoga Capital Advisors, LLC

1.42M

-9.51%

LeMaitre (George W)

1.50M

-3.91%

First Trust Advisors L.P.

940.14K

+13.41%

Copeland Capital Management, LLC

888.98K

-5.46%

Congress Asset Management Company, LLP

732.33K

+5.79%

State Street Investment Management (US)

806.99K

+0.77%

Geneva Capital Management LLC

814.68K

-10.70%

Geode Capital Management, L.L.C.

633.09K

+20.09%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of LeMaitre Vascular Inc is 8.70, ranking 18 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.57. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. LeMaitre Vascular Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

LeMaitre Vascular Inc

LMAT

7.67 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment